{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T00:53:56Z","timestamp":1791161636081,"version":"4.1.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2006,8,1]],"date-time":"2006-08-01T00:00:00Z","timestamp":1154390400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mayo Clinic Proceedings"],"published-print":{"date-parts":[[2006,8]]},"DOI":"10.4065\/81.8.1013","type":"journal-article","created":{"date-parts":[[2009,1,24]],"date-time":"2009-01-24T01:27:47Z","timestamp":1232760467000},"page":"1013-1022","source":"Crossref","is-referenced-by-count":574,"title":["Adherence to Bisphosphonate Therapy and Fracture Rates in Osteoporotic Women: Relationship to Vertebral and Nonvertebral Fractures From 2 US Claims Databases"],"prefix":"10.4065","volume":"81","author":[{"given":"Ethel S.","family":"Siris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven T.","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford J.","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles E.","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James N.","family":"Arvesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Abbott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"Silverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.4065\/81.8.1013_bib1","author":"National Osteoporosis Foundation"},{"key":"10.4065\/81.8.1013_bib2","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jbmr.5650100202","article-title":"How many women have osteoporosis now?","volume":"10","author":"Melton","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.4065\/81.8.1013_bib3","first-page":"203","article-title":"ACOG practice bulletin: clinical management guidelines for obstetrician-gynecologists: number 50, January 2004","volume":"103","author":"American College of Obstetrics and Gynecology Committee on Practice Bulletins","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.4065\/81.8.1013_bib4","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1179\/acb.2002.054","article-title":"Management of primary osteoporosis","volume":"57","author":"Body","year":"2002","journal-title":"Acta Clin Belg"},{"key":"10.4065\/81.8.1013_bib5","series-title":"Osteoporosis: New Perspectives on Causes, Prevention, and Treatment","first-page":"1","article-title":"Epidemiology and definition of osteoporosis","author":"Cooper","year":"1996"},{"issue":"suppl 2A","key":"10.4065\/81.8.1013_bib6","doi-asserted-by":"crossref","first-page":"3S","DOI":"10.1016\/S0002-9343(05)80037-3","article-title":"The economic and human costs of osteoporotic fracture","volume":"98","author":"Barrett-Connor","year":"1995","journal-title":"Am J Med"},{"key":"10.4065\/81.8.1013_bib7","first-page":"1293","article-title":"Pharmacologic prevention of osteoporotic fractures","volume":"70","author":"Zizic","year":"2004","journal-title":"Am Fam Physician"},{"key":"10.4065\/81.8.1013_bib8","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.4065\/81.8.1013_bib9","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/PL00004171","article-title":"Multinational, placebo-controlled, randomized trial of the effects of alendronate on bone density and fracture risk in postmenopausal women with low bone mass: results of the FOSIT study","volume":"9","author":"Pols","year":"1999","journal-title":"Osteoporos Int"},{"key":"10.4065\/81.8.1013_bib10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s001980050010","article-title":"Randomized trial of the effects of risedronate on vertebral fractures in women with established postmenopausal osteoporosis","volume":"11","author":"Reginster","year":"2000","journal-title":"Osteoporos Int"},{"issue":"suppl 1","key":"10.4065\/81.8.1013_bib11","first-page":"S15","article-title":"Oral ibandronate significantly reduces fracture risk in postmenopausal osteoporosis when administered daily or with a unique drug-free interval: results from a pivotal phase III study [abstract]","volume":"13","author":"Delmas","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.4065\/81.8.1013_bib12","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.4065\/81.8.1013_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0002-9343(03)00362-0","article-title":"Early discontinuation of treatment for osteoporosis","volume":"115","author":"Tosteson","year":"2003","journal-title":"Am J Med"},{"key":"10.4065\/81.8.1013_bib14","first-page":"859","article-title":"Compliance of osteoporotic patients with different treatment regimens","volume":"5","author":"Segal","year":"2003","journal-title":"Isr Med Assoc J"},{"key":"10.4065\/81.8.1013_bib15","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.maturitas.2004.02.005","article-title":"Compliance with drug therapies for the treatment and prevention of osteoporosis","volume":"48","author":"McCombs","year":"2004","journal-title":"Maturitas"},{"key":"10.4065\/81.8.1013_bib16","first-page":"713","article-title":"Randomized database studies: a new method to assess drugs' effectiveness?","volume":"51","author":"Sacristan","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.4065\/81.8.1013_bib17","doi-asserted-by":"crossref","first-page":"142","DOI":"10.18553\/jmcp.2004.10.2.142","article-title":"Comparison of risedronate to alendronate and calcitonin for early reduction of nonvertebral fracture risk: results from a managed care administrative claims database","volume":"10","author":"Watts","year":"2004","journal-title":"J Manag Care Pharm"},{"key":"10.4065\/81.8.1013_bib18","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2165\/00019053-199304050-00003","article-title":"The role of insurance claims databases in drug therapy outcomes research","volume":"4","author":"Lewis","year":"1993","journal-title":"Pharmacoeconomics"},{"key":"10.4065\/81.8.1013_bib19","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00198-004-1652-z","article-title":"The impact of compliance with osteoporosis therapy on fracture rates in actual practice","volume":"15","author":"Caro","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.4065\/81.8.1013_bib20","doi-asserted-by":"crossref","first-page":"856","DOI":"10.4065\/80.7.856","article-title":"Effect of dosing frequency on bisphosphonate medication adherence in a large longitudinal cohort of women","volume":"80","author":"Recker","year":"2005","journal-title":"Mayo Clin Proc"},{"key":"10.4065\/81.8.1013_bib21","unstructured":"Weycker D, Macarios D, Oster G. Adherence with weekly versus daily bisphosphonate therapy among women with postmenopausal osteoporosis. Presented at: Annual Meeting of the American Society for Bone and Mineral Research; Nashville, Tenn; September 23-27, 2005. Poster SU397."},{"key":"10.4065\/81.8.1013_bib22","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1001\/archinte.165.20.2414","article-title":"Compliance with osteoporosis medications","volume":"165","author":"Solomon","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.4065\/81.8.1013_bib23","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1378\/chest.116.4.968","article-title":"Predicting active pulmonary tuberculosis using an artificial neural network","volume":"116","author":"El-Solh","year":"1999","journal-title":"Chest"},{"key":"10.4065\/81.8.1013_bib24","first-page":"449","article-title":"Estimating medication persistency using administrative claims data","volume":"11","author":"Sikka","year":"2005","journal-title":"Am J Manag Care"},{"key":"10.4065\/81.8.1013_bib25","first-page":"489","article-title":"Effect of health education in promoting prescription refill compliance among patients with hypertension","volume":"13","author":"Sclar","year":"1991","journal-title":"Clin Ther"},{"key":"10.4065\/81.8.1013_bib26","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1097\/00042192-199805040-00008","article-title":"Patient noncompliance with hormone replacement therapy: a nationwide estimate using a large prescription claims database","volume":"5","author":"Faulkner","year":"1998","journal-title":"Menopause"},{"key":"10.4065\/81.8.1013_bib27","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1185\/030079905X61875","article-title":"Compliance and persistence with bisphosphonate dosing regimens among women with postmenopausal osteoporosis","volume":"21","author":"Cramer","year":"2005","journal-title":"Curr Med Res Opin"},{"issue":"suppl 1","key":"10.4065\/81.8.1013_bib28","first-page":"S529","article-title":"Compliance with alendronate treatment in an osteoporosis clinic [abstract]","volume":"16","author":"Lombas","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.4065\/81.8.1013_bib29","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/j.bone.2005.10.022","article-title":"Assessment of compliance with osteoporosis treatment and its consequences in a managed care population","volume":"38","author":"Huybrechts","year":"2006","journal-title":"Bone"},{"key":"10.4065\/81.8.1013_bib30","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s00198-004-1597-2","article-title":"A prospective clinical practice intervention to improve osteoporosis management following distal forearm fracture","volume":"15","author":"Cuddihy","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.4065\/81.8.1013_bib31","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1210\/jc.2003-030501","article-title":"The impact of monitoring on adherence and persistence with antiresorptive treatment for postmenopausal osteoporosis: a randomized controlled trial","volume":"89","author":"Clowes","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.4065\/81.8.1013_bib32","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/S0149-2918(01)80109-0","article-title":"A systematic review of the associations between dose regimens and medication compliance","volume":"23","author":"Claxton","year":"2001","journal-title":"Clin Ther"},{"key":"10.4065\/81.8.1013_bib33","doi-asserted-by":"crossref","first-page":"1871","DOI":"10.1016\/S0149-2918(02)80085-6","article-title":"Patient preference for once-weekly alendronate 70 mg versus once-daily alendronate 10 mg: a multicenter, randomized, open-label, cross-over study","volume":"24","author":"Simon","year":"2002","journal-title":"Clin Ther"},{"key":"10.4065\/81.8.1013_bib34","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1185\/030079905X74862","article-title":"Patient preference for once-monthly ibandronate versus once-weekly alendronate in a randomized, open-label, cross-over trial: the Boniva Alendronate Trial in Osteoporosis (BALTO)","volume":"21","author":"Emkey","year":"2005","journal-title":"Curr Med Res Opin"},{"key":"10.4065\/81.8.1013_bib35","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1007\/s00198-004-1818-8","article-title":"Correlation between patient recall of bone densitometry results and subsequent treatment adherence","volume":"16","author":"Pickney","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.4065\/81.8.1013_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/s11914-005-0014-x","article-title":"Review of guidelines for bone mineral density testing and treatment of osteoporosis","volume":"3","author":"Lewiecki","year":"2005","journal-title":"Curr Osteoporos Rep"},{"key":"10.4065\/81.8.1013_bib37","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1002\/art.21072","article-title":"Redesigning the care of fragility fracture patients to improve osteoporosis management: a health care improvement project","volume":"53","author":"Harrington","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.4065\/81.8.1013_bib38","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1056\/NEJMp038145","article-title":"Population-based studies of adverse drug effects","volume":"349","author":"Ray","year":"2003","journal-title":"N Engl J Med"},{"key":"10.4065\/81.8.1013_bib39","first-page":"541","article-title":"Internal validation of Medicare claims data","volume":"5","author":"Baron","year":"1994","journal-title":"Epidemiology"},{"key":"10.4065\/81.8.1013_bib40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJMcp042092","article-title":"Screening for osteoporosis","volume":"353","author":"Raisz","year":"2005","journal-title":"N Engl J Med"}],"container-title":["Mayo Clinic Proceedings"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611612019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025619611612019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,9,30]],"date-time":"2021-09-30T14:02:55Z","timestamp":1633010575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025619611612019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2006,8]]}},"alternative-id":["S0025619611612019"],"URL":"https:\/\/doi.org\/10.4065\/81.8.1013","relation":{},"ISSN":["0025-6196"],"issn-type":[{"value":"0025-6196","type":"print"}],"subject":[],"published":{"date-parts":[[2006,8]]}}}